Suma M. Krishnan - President, R&D, Director, 10%+ Owner at Krystal Biotech, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, R&D, Director, 10%+ Owner
Issuer Symbol
KRYS on Nasdaq
All Insider Reports
All Insider Reports

Suma M. Krishnan - trading volume in the past year for Krystal Biotech, Inc.

Holdings reported by Suma M. Krishnan for Krystal Biotech, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,413,711 $314,373,983 $222.38 04 Dec 2025 Direct
Common Stock 1,478,056 $297,399,647 $201.21 05 Dec 2025 By Spouse
Common Stock 90,000 $18,108,900 $201.21 04 Dec 2025 By SMK Trust
Common Stock 50,000 $10,060,500 $201.21 04 Dec 2025 By Krishnan Family Trust
Performance Stock Units 22,500 $3,968,775 $176.39 28 Feb 2025 Direct Common Stock
Restricted Stock Units 16,000 $2,822,240 $176.39 28 Feb 2025 Direct Common Stock
Stock Option (Right to Buy) 25,000 $2,047,750 $81.91 28 Feb 2025 Direct Common Stock

Transactions reported by Suma M. Krishnan for Krystal Biotech, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.